Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-199060
Filing Date
2014-05-14
Accepted
2014-05-14 16:10:55
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d704193d10q.htm 10-Q 310486
2 EX-31.1 d704193dex311.htm EX-31.1 7018
3 EX-31.2 d704193dex312.htm EX-31.2 6718
4 EX-32.1 d704193dex321.htm EX-32.1 7786
  Complete submission text file 0001193125-14-199060.txt   3439191

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT srne-20140331.xml EX-101.INS 355501
6 XBRL TAXONOMY EXTENSION SCHEMA srne-20140331.xsd EX-101.SCH 36305
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20140331_cal.xml EX-101.CAL 43742
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20140331_def.xml EX-101.DEF 130369
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20140331_lab.xml EX-101.LAB 333920
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20140331_pre.xml EX-101.PRE 223341
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 14841626
SIC: 8731 Services-Commercial Physical & Biological Research